5-Methyl-2-Pyrazinecarboxylic Acid CAS 5521-55-1 Tsafta > 99.0% (HPLC)
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 5-Methyl-2-Pyrazinecarboxylic Acid (CAS: 5521-55-1) with high quality. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com
Sunan Sinadari | 5-Methyl-2-Pyrazinecarboxylic Acid |
Makamantu | 5-Methylpyrazine-2-Carboxylic Acid |
Lambar CAS | 5521-55-1 |
Lambar CAT | Saukewa: RF-PI2146 |
Matsayin Hannun jari | A Hannun jari, Iyawar Samar da Ton 20/wata |
Tsarin kwayoyin halitta | Saukewa: C6H6N2O2 |
Nauyin Kwayoyin Halitta | 138.12 |
Alamar | Ruifu Chemical |
Abu | Ƙayyadaddun bayanai |
Bayyanar | Kashe-White Crystallized Foda |
Tsarkake / Hanyar Bincike | > 99.0% (HPLC) |
Matsayin narkewa | 164.0 ~ 168.0 ℃ |
Ruwa (na Karl Fischer) | <0.50% |
Rashin Najasa Guda Daya | <0.50% |
Jimlar ƙazanta | <1.00% |
Abubuwan da aka bayar na Proton NMR Spectrum | Yayi daidai da Tsarin |
Matsayin Gwaji | Matsayin Kasuwanci |
Amfani | Matsakaicin Magunguna;Acipimox Intermediate |
Kunshin: Bottle, Aluminum tsare jakar, 25kg / kwali Drum, ko bisa ga abokin ciniki ta bukata
Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi
5-Methyl-2-Pyrazinecarboxylic Acid (CAS: 5521-55-1) wani muhimmin matsakaicin magunguna ne, ana amfani da shi don matsakaicin Acipimox.Acipimox analog ne mai ƙarfi na antilipolytic nicotinic acid (NA).Kamar nicotinic acid, acipimox yana rage yawan lipids yadda ya kamata, amma ba kamar nicotinic acid ba, acipimox ya daɗe yana aiki kuma don haka ya fi sauƙi don samar da fatty acid sake dawowa.Ana ba da shawarar Acipimox azaman wakili mai rage lipid don kula da hyperlipidemia a cikin marasa lafiya da ke fama da ciwon sukari wanda ba ya dogara da insulin.Acipimox wakili ne na hypolipidemic wanda ke da alaƙa da acid nicotinic tare da bayyananniyar ayyukan antilipolytic mai dorewa.Baya ga aikin rage yawan lipid ɗin sa, yana haifar da haɓaka mai fa'ida na haɓakar haɓakar ƙwayar cuta mai yawa na anti-atherogenic babban adadin lipoprotein, HDL2.